rs113904350

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_199242.3(UNC13D):​c.*64C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00601 in 1,570,002 control chromosomes in the GnomAD database, including 90 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0079 ( 13 hom., cov: 33)
Exomes 𝑓: 0.0058 ( 77 hom. )

Consequence

UNC13D
NM_199242.3 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.822

Publications

1 publications found
Variant links:
Genes affected
UNC13D (HGNC:23147): (unc-13 homolog D) This gene encodes a protein that is a member of the UNC13 family, containing similar domain structure as other family members but lacking an N-terminal phorbol ester-binding C1 domain present in other Munc13 proteins. The protein appears to play a role in vesicle maturation during exocytosis and is involved in regulation of cytolytic granules secretion. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 3, a genetically heterogeneous, rare autosomal recessive disorder. [provided by RefSeq, Jul 2008]
UNC13D Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 17-75827901-G-A is Benign according to our data. Variant chr17-75827901-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 325239.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0079 (1204/152320) while in subpopulation AFR AF = 0.0136 (566/41576). AF 95% confidence interval is 0.0127. There are 13 homozygotes in GnomAd4. There are 531 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UNC13DNM_199242.3 linkc.*64C>T 3_prime_UTR_variant Exon 32 of 32 ENST00000207549.9 NP_954712.1 Q70J99-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UNC13DENST00000207549.9 linkc.*64C>T 3_prime_UTR_variant Exon 32 of 32 1 NM_199242.3 ENSP00000207549.3 Q70J99-1

Frequencies

GnomAD3 genomes
AF:
0.00787
AC:
1198
AN:
152202
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0135
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00634
Gnomad ASJ
AF:
0.0331
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0137
Gnomad FIN
AF:
0.000470
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00471
Gnomad OTH
AF:
0.0143
GnomAD4 exome
AF:
0.00581
AC:
8239
AN:
1417682
Hom.:
77
Cov.:
31
AF XY:
0.00612
AC XY:
4299
AN XY:
702930
show subpopulations
African (AFR)
AF:
0.0140
AC:
452
AN:
32230
American (AMR)
AF:
0.00641
AC:
259
AN:
40430
Ashkenazi Jewish (ASJ)
AF:
0.0358
AC:
908
AN:
25360
East Asian (EAS)
AF:
0.000324
AC:
12
AN:
37012
South Asian (SAS)
AF:
0.0142
AC:
1162
AN:
82058
European-Finnish (FIN)
AF:
0.000737
AC:
32
AN:
43432
Middle Eastern (MID)
AF:
0.0273
AC:
112
AN:
4104
European-Non Finnish (NFE)
AF:
0.00439
AC:
4802
AN:
1094410
Other (OTH)
AF:
0.00853
AC:
500
AN:
58646
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
501
1003
1504
2006
2507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00790
AC:
1204
AN:
152320
Hom.:
13
Cov.:
33
AF XY:
0.00713
AC XY:
531
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0136
AC:
566
AN:
41576
American (AMR)
AF:
0.00634
AC:
97
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0331
AC:
115
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.0133
AC:
64
AN:
4830
European-Finnish (FIN)
AF:
0.000470
AC:
5
AN:
10628
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00471
AC:
320
AN:
68004
Other (OTH)
AF:
0.0142
AC:
30
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
63
125
188
250
313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00664
Hom.:
1
Bravo
AF:
0.00851
Asia WGS
AF:
0.00693
AC:
24
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial hemophagocytic lymphohistiocytosis 3 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
5.7
DANN
Benign
0.82
PhyloP100
0.82
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113904350; hg19: chr17-73823982; API